Ferrer Has Completed Patient Recruitment for PROSPER Study BlogCommunicationsInformation & SupportResearch Ferrer Has Completed Patient Recruitment for PROSPER Study Spanish pharmaceutical company, Ferrer, have announced they have completed recruitment of 220 patients for the…Colleen Wren22nd October 2025
Amylyx Pharmaceuticals discontinue clinical trial for PSP CommunicationsResearch Amylyx Pharmaceuticals discontinue clinical trial for PSP This week, Amylyx Pharmaceuticals has made the decision to discontinue their Orion trial of AMX0035…PSPA Admin28th August 2025
Ferrer advances research into PSP CommunicationsResearch Ferrer advances research into PSP We are excited to learn Ferrer has advanced their research into PSP with a phase…PSPA Admin1st October 2024
An update on the Amylyx Orion clinical trial CommunicationsResearch An update on the Amylyx Orion clinical trial Last week, Amylyx published news about their Orion clinical trial which was due to introduce…PSPA Admin23rd April 2024
First participant dosed in the Amylyx trial BlogResearch First participant dosed in the Amylyx trial The first participant in the Amylyx stage three trial began receiving doses before Christmas! The…PSPA Admin23rd January 2024